Skip to main content
46°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
8
9
Next >
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
November 08, 2024
Tags
AstraZeneca PLC
Health care industry
Health & Science
From
CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
October 31, 2024
Tags
Healthy Returns
Biotech and Pharmaceuticals
Science
From
CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
October 30, 2024
Tags
Business
Health & Science
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
Tags
Business
Health & Science
Obesity
From
CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
October 23, 2024
Tickers
HIMS
LLY
NEWS
NVO
Tags
wegovy
semaglutide
Benzinga
From
Benzinga
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
October 23, 2024
Tags
Health care industry
Health & Science
Social issues
From
CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
October 23, 2024
Tags
Biotech and Pharmaceuticals
US: News
Business News
From
CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
October 15, 2024
Tags
Health & Science
Social issues
Abbott Laboratories
From
CNBC.com News
Cramer's Lightning Round: Uranium Energy is 'the real deal'
October 14, 2024
Tags
Business News
Market Outlook
Markets
From
CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
October 11, 2024
Tags
Europe: Top News And Analysis
Pharmaceuticals
Europe News
From
CNBC.com News
Ozempic underworld: Inside the black market of obesity drugs
October 09, 2024
Tags
CNBC Investigations
Health care industry
Novo Nordisk A/S
From
CNBC.com News
CNBC Daily Open: October’s gravity bringing stocks down
October 04, 2024
Tickers
JOBS
OIL
Tags
Daily Open
Markets
China Markets
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
October 03, 2024
Tags
Alibaba Group Holding Ltd
Investment strategy
Tesla Inc
From
CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
October 01, 2024
Tags
Economy
Obesity
Drug Retail
From
CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
October 01, 2024
Tags
Transportation Infrastructure
U/S/ Economy
Eli Lilly and Co
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
September 25, 2024
Tags
Business
Eli Lilly and Co
Social issues
From
CNBC.com News
5 things to know before the stock market opens Wednesday
September 25, 2024
Tags
Technology
Markets
Investing
From
CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
Tags
Novo Nordisk A/S
Astellas Pharma Inc
Healthy Returns
From
CNBC.com News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
September 24, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
September 23, 2024
Tags
Century Communities Inc
Entergy Corp
Meta Platforms Inc
From
CNBC.com News
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
September 22, 2024
Tickers
NEWS
NVO
Tags
Novo Nordisk A/S
fat loss
News
From
Benzinga
FTC sues drug middlemen for allegedly inflating insulin prices
September 20, 2024
Tags
Politics
Business
Eli Lilly and Co
From
CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
September 18, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Biotechnology
From
CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
September 17, 2024
Tags
Novo Nordisk A/S
Healthy Returns
Biotech and Pharmaceuticals
From
CNBC.com News
How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
September 16, 2024
Tags
Apple Inc
Economic events
Business
From
CNBC.com News
CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
September 12, 2024
Tickers
JOBS
Tags
Daily Open
Roche Holding AG
Technology
From
CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
September 12, 2024
Tags
Pharmaceuticals
Companies
Health care industry
From
CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
Tags
Healthy Returns
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
Tags
Novo Nordisk A/S
Healthy Returns
Biotech and Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Tuesday
September 03, 2024
Tags
Economy
Investing
Markets
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.